Among 342 sporadic CRC patients with available DNA in tumor tissues, the somatic mutation frequencies in hMLH1 and hMSH2 genes were 6.73% (23/342) and 11.70% (40/342), respectively (p = 0.02) (Table 3). The gene discussed is MSH2; the disease is colorectal carcinoma.